Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

OXACILLIN SODIUM

OXACILLIN SODIUM

Standard Dose
EQ 500MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview OXACILLIN SODIUM is listed in Drugs@FDA under application 062856 (ANDA).

Marketing status: Discontinued Active ingredient OXACILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 500MG BASE/VIAL Sponsor WATSON LABS INC Submission history Latest submission status date: 2000-12-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview OXACILLIN SODIUM is listed in Drugs@FDA under application 062856 (ANDA). Marketing status: Discontinued Active ingredient OXACILLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 500MG BASE/VIAL Sponsor WATSON LABS INC Submission history Latest submission status date: 2000-12-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
OXACILLIN SODIUM (OXACILLIN SODIUM) | Drug Monograph | MedicHelpline